Cargando…
ATM c.7570G>C is a high‐risk allele for breast cancer
ATM is generally described as a moderate‐risk breast cancer susceptibility gene. However, some of ATM variants might encounter higher risk. ATM c.7570G>C, p.Ala2524Pro, (rs769142993) is a pathogenic Finnish founder variant causative for recessively inherited ataxia‐telangiectasia. At cellular lev...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092731/ https://www.ncbi.nlm.nih.gov/pubmed/36161273 http://dx.doi.org/10.1002/ijc.34305 |
_version_ | 1785023419002126336 |
---|---|
author | Kankuri‐Tammilehto, Minna Tervasmäki, Anna Kraatari‐Tiri, Minna Rahikkala, Elisa Pylkäs, Katri Kuismin, Outi |
author_facet | Kankuri‐Tammilehto, Minna Tervasmäki, Anna Kraatari‐Tiri, Minna Rahikkala, Elisa Pylkäs, Katri Kuismin, Outi |
author_sort | Kankuri‐Tammilehto, Minna |
collection | PubMed |
description | ATM is generally described as a moderate‐risk breast cancer susceptibility gene. However, some of ATM variants might encounter higher risk. ATM c.7570G>C, p.Ala2524Pro, (rs769142993) is a pathogenic Finnish founder variant causative for recessively inherited ataxia‐telangiectasia. At cellular level, it has been reported to have a dominant‐negative effect. ATM c.7570G>C has recurrently been described in Finnish breast cancer families and unselected case cohorts collected from different parts of the country, but the rarity of the allele (MAF 0.0002772 in Finns) and lack of confirming segregation analyses have prevented any conclusive risk estimates. Here, we describe seven families from genetic counseling units with ATM c.7570G>C variant showing co‐segregation with breast cancer. Further analysis of the unselected breast cancer cohort from Northern Finland (n = 1822), a geographical region previously indicated to have enrichment of the variant, demonstrated that c.7570G>C significantly associates with breast cancer, and the risk is estimated as high (odds ratio [OR] = 8.5, 95% confidence interval [CI] = 1.04‐62.46, P = .018). Altogether, these results place ATM c.7570G>C variant among the high‐risk alleles for breast cancer, which should be taken into consideration in genetic counseling. |
format | Online Article Text |
id | pubmed-10092731 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100927312023-04-13 ATM c.7570G>C is a high‐risk allele for breast cancer Kankuri‐Tammilehto, Minna Tervasmäki, Anna Kraatari‐Tiri, Minna Rahikkala, Elisa Pylkäs, Katri Kuismin, Outi Int J Cancer Cancer Genetics and Epigenetics ATM is generally described as a moderate‐risk breast cancer susceptibility gene. However, some of ATM variants might encounter higher risk. ATM c.7570G>C, p.Ala2524Pro, (rs769142993) is a pathogenic Finnish founder variant causative for recessively inherited ataxia‐telangiectasia. At cellular level, it has been reported to have a dominant‐negative effect. ATM c.7570G>C has recurrently been described in Finnish breast cancer families and unselected case cohorts collected from different parts of the country, but the rarity of the allele (MAF 0.0002772 in Finns) and lack of confirming segregation analyses have prevented any conclusive risk estimates. Here, we describe seven families from genetic counseling units with ATM c.7570G>C variant showing co‐segregation with breast cancer. Further analysis of the unselected breast cancer cohort from Northern Finland (n = 1822), a geographical region previously indicated to have enrichment of the variant, demonstrated that c.7570G>C significantly associates with breast cancer, and the risk is estimated as high (odds ratio [OR] = 8.5, 95% confidence interval [CI] = 1.04‐62.46, P = .018). Altogether, these results place ATM c.7570G>C variant among the high‐risk alleles for breast cancer, which should be taken into consideration in genetic counseling. John Wiley & Sons, Inc. 2022-10-06 2023-02-01 /pmc/articles/PMC10092731/ /pubmed/36161273 http://dx.doi.org/10.1002/ijc.34305 Text en © 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Cancer Genetics and Epigenetics Kankuri‐Tammilehto, Minna Tervasmäki, Anna Kraatari‐Tiri, Minna Rahikkala, Elisa Pylkäs, Katri Kuismin, Outi ATM c.7570G>C is a high‐risk allele for breast cancer |
title |
ATM c.7570G>C is a high‐risk allele for breast cancer |
title_full |
ATM c.7570G>C is a high‐risk allele for breast cancer |
title_fullStr |
ATM c.7570G>C is a high‐risk allele for breast cancer |
title_full_unstemmed |
ATM c.7570G>C is a high‐risk allele for breast cancer |
title_short |
ATM c.7570G>C is a high‐risk allele for breast cancer |
title_sort | atm c.7570g>c is a high‐risk allele for breast cancer |
topic | Cancer Genetics and Epigenetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092731/ https://www.ncbi.nlm.nih.gov/pubmed/36161273 http://dx.doi.org/10.1002/ijc.34305 |
work_keys_str_mv | AT kankuritammilehtominna atmc7570gcisahighriskalleleforbreastcancer AT tervasmakianna atmc7570gcisahighriskalleleforbreastcancer AT kraataritiriminna atmc7570gcisahighriskalleleforbreastcancer AT rahikkalaelisa atmc7570gcisahighriskalleleforbreastcancer AT pylkaskatri atmc7570gcisahighriskalleleforbreastcancer AT kuisminouti atmc7570gcisahighriskalleleforbreastcancer |